Grotex

Solopharm, legally known as Grotex LLC, is a prominent Russian pharmaceutical manufacturer specializing in liquid dosage forms and biotechnological products. Established in 2010 and headquartered in St. Petersburg, the company operates a state-of-the-art facility that utilizes advanced Blow-Fill-Seal (BFS) technology for sterile production. Solopharm's extensive portfolio covers therapeutic areas such as ophthalmology, rheumatology, and respiratory medicine, offering both generic and original medications. The company has recently expanded its capabilities to include a dedicated biotechnology plant for the production of monoclonal antibodies and other complex biologics. Solopharm is recognized for its high level of automation and its significant role in the Russian pharmaceutical market's import substitution efforts.